Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Colcher

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988
Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibodyJ A Carrasquillo, P Sugarbaker, D Colcher, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Tumor targeting with monoclonal antibody B72.3J Schlom, D Colcher, M Roselli, et al.
Cancer Research|February 1, 1990
Innovations that influence the pharmacology of monoclonal antibody guided tumor targetingJ Schlom, P H Hand, J W Greiner, et al.
Cancer|February 1, 1994
Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugatesM E Schott, J Schlom, K Siler, et al.
Leukemia & Lymphoma|May 16, 2000
Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphomaJ M Vose, D Colcher, L Gobar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1989
Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancerK Yokoyama, J A Carrasquillo, A E Chang, et al.
Cancer Treatment and Research|January 1, 1990
Tumor targeting with monoclonal antibody B72.3: experimental and clinical resultsJ Schlom, D Colcher, K Siler, et al.
Journal of the National Cancer Institute|July 18, 1990
In vivo tumor targeting of a recombinant single-chain antigen-binding proteinD Colcher, R Bird, M Roselli, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Comparison of bone marrow dosimetry and toxic effect of high dose 131I-labeled monoclonal antibodies administered to manS M Larson, A Raubitschek, J C Reynolds, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992
Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancerR F Meredith, M B Khazaeli, T Liu, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988
Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibodyJ A Carrasquillo, P Sugarbaker, D Colcher, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Tumor targeting with monoclonal antibody B72.3J Schlom, D Colcher, M Roselli, et al.
Cancer Research|February 1, 1990
Innovations that influence the pharmacology of monoclonal antibody guided tumor targetingJ Schlom, P H Hand, J W Greiner, et al.
Cancer|February 1, 1994
Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugatesM E Schott, J Schlom, K Siler, et al.
Leukemia & Lymphoma|May 16, 2000
Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphomaJ M Vose, D Colcher, L Gobar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1989
Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancerK Yokoyama, J A Carrasquillo, A E Chang, et al.
Cancer Treatment and Research|January 1, 1990
Tumor targeting with monoclonal antibody B72.3: experimental and clinical resultsJ Schlom, D Colcher, K Siler, et al.
Journal of the National Cancer Institute|July 18, 1990
In vivo tumor targeting of a recombinant single-chain antigen-binding proteinD Colcher, R Bird, M Roselli, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Comparison of bone marrow dosimetry and toxic effect of high dose 131I-labeled monoclonal antibodies administered to manS M Larson, A Raubitschek, J C Reynolds, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992
Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancerR F Meredith, M B Khazaeli, T Liu, et al.
Pageof 14